Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of Human T-cell Leukemia Virus Antibodies among Young Females Attending a Large Medical Diagnostic Laboratory in Neyshabour, Northeast of Iran, During 2011 to 2015

Masoud Mobini 1 and Mohammad Salehi 2 , *
Authors Information
1 Young Researchers and Elite Clup, Tonekabon Branch, Islamic Azad University, Tonekabon, IR Iran
2 Blood Borne Infections Research Center, Razavi Khorasan Branch, Academic Center for Education, Culture and Research (ACECR), Mashhad, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: June 2018, 13 (3); e62305
  • Published Online: June 27, 2018
  • Article Type: Brief Report
  • Received: November 26, 2016
  • Revised: September 28, 2017
  • Accepted: February 17, 2018
  • DOI: 10.5812/archcid.62305

To Cite: Mobini M, Salehi M. Prevalence of Human T-cell Leukemia Virus Antibodies among Young Females Attending a Large Medical Diagnostic Laboratory in Neyshabour, Northeast of Iran, During 2011 to 2015, Arch Clin Infect Dis. 2018 ; 13(3):e62305. doi: 10.5812/archcid.62305.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results and Discussion
  • 1. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2011;13(6):424-7. [PubMed: 22737506]. [PubMed Central: PMC3371930].
  • 2. Salehi M, Shokouhi Mostafavi SK, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 Infection in Neyshabur City, North-Eastern Iran, during 2010-2014. Iran Biomed J. 2017;21(1):57-60. [PubMed: 26899860]. [PubMed Central: PMC5141255].
  • 3. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266-81. doi: 10.1016/s1473-3099(07)70081-6.
  • 4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. doi: 10.1038/sj.onc.1208968. [PubMed: 16155612].
  • 5. Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Glob J Health Sci. 2014;6(5):99-104. doi: 10.5539/gjhs.v6n5p99. [PubMed: 25168999]. [PubMed Central: PMC4825399].
  • 6. Rafatpanah H, Fathimoghadam F, Shahabi M, Eftekharzadeh I, Hedayati-Moghaddam M, Valizadeh N, et al. No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran. Iran J Basic Med Sci. 2013;16(3):229-34. [PubMed: 24470868]. [PubMed Central: PMC3881255].
  • 7. Maghsudlu M, Safabakhsh H, Jamili P. Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar. Asian J Transfus Sci. 2015;9(2):203-6. doi: 10.4103/0973-6247.154255. [PubMed: 26420946]. [PubMed Central: PMC4562147].
  • 8. Armah HB, Narter-Olaga EG, Adjei AA, Asomaning K, Gyasi RK, Tettey Y. Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. J Med Microbiol. 2006;55(Pt 6):765-70. doi: 10.1099/jmm.0.46426-0. [PubMed: 16687597].
  • 9. Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006;78(5):683-92. doi: 10.1002/jmv.20593. [PubMed: 16555290].
  • 10. Etenna SL, Caron M, Besson G, Makuwa M, Gessain A, Mahe A, et al. New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa. J Clin Microbiol. 2008;46(11):3607-14. doi: 10.1128/JCM.01249-08. [PubMed: 18845819]. [PubMed Central: PMC2576568].
  • 11. Maloney EM, Yamano Y, Vanveldhuisen PC, Sawada T, Kim N, Cranston B, et al. Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. J Infect Dis. 2006;194(5):552-60. doi: 10.1086/506365. [PubMed: 16897651].
  • 12. Tortevoye P, Tuppin P, Carles G, Peneau C, Gessain A. Comparative trends of seroprevalence and seroincidence rates of human T cell lymphotropic virus type I and human immunodeficiency virus 1 in pregnant women of various ethnic groups sharing the same environment in French Guiana. Am J Trop Med Hyg. 2005;73(3):560-5. [PubMed: 16172481].
  • 13. Maehama T. Human T cell leukemia virus-1 in pregnancy. Int J Gynaecol Obstet. 2004;87(3):247-8. doi: 10.1016/j.ijgo.2004.07.024. [PubMed: 15548399].
  • 14. Taylor GP, Bodeus M, Courtois F, Pauli G, Del Mistro A, Machuca A, et al. The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr. 2005;38(1):104-9. [PubMed: 15608533].
  • 15. Tseliou PM, Spanakis N, Spiliotakara A, Markogiannakis A, Legakis NJ, Tsakris A. Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. Int J STD AIDS. 2006;17(8):543-6. doi: 10.1258/095646206778145541. [PubMed: 16925902].
  • 16. Ydy RR, Ferreira D, Souto FJ, Fontes CJ. [Prevalence of human T-cell lymphotropic virus (HTLV-1/2) infection among puerperae in Cuiaba, Mato Grosso, 2006]. Rev Soc Bras Med Trop. 2009;42(1):28-32. [PubMed: 19287932].
  • 17. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388. doi: 10.3389/fmicb.2012.00388. [PubMed: 23162541]. [PubMed Central: PMC3498738].
  • 18. Alarcon JO, Friedman HB, Montano SM, Zunt JR, Holmes KK, Quinnan GV Jr. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru. J Acquir Immune Defic Syndr. 2006;42(5):604-9. doi: 10.1097/01.qai.0000221680.52563.d5. [PubMed: 16773029]. [PubMed Central: PMC2683844].
  • 19. Trenchi A, Gastaldello R, Balangero M, Irizar M, Cudola A, Gallego S. Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina. J Med Virol. 2007;79(12):1974-8. doi: 10.1002/jmv.21027. [PubMed: 17935192].
  • 20. Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, et al. Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)–Infected Individuals Without HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study. Clin Infect Dis. 2015;61(1):49-56. doi: 10.1093/cid/civ229.
  • 21. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007;17(6):425-33. doi: 10.1111/j.1365-3148.2007.00794.x. [PubMed: 18067646].
  • 22. Salehi M, Mobini M. The seroepidemiological of Human T-lymphotropic virus on children, teenage and juveniles in Nyshabor city. Iran J Med Microbiol. 2015;9(3):31-5.
  • 23. Salehi M, Afrisham M. The seroepidemiological survey of HTLV1, 2 infections in Nyshabor city (Northeast of Iran). Lab Diagnos. 2014;6(23):35-8.
  • 24. Mortezaie Z, Bouzari M, Roghanian R. Evaluating the frequency of HTLV-Ι/II infection among blood donors, major thalassemic patients and individuals infected with hepatitis B and C viruses in Isfahan, Iran. Iran J Blood Cancer. 2012;4(2):75-80.
  • 25. Okoye AE, Ibegbulam OG, Onoh RC, Ezeonu PO, Ugwu NI, Lawani LO, et al. Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Int J Womens Health. 2014;6:849-55. doi: 10.2147/IJWH.S64199. [PubMed: 25258559]. [PubMed Central: PMC4174018].
  • 26. Monteiro DL, Taquette SR, Sodre Barmpas DB, Rodrigues NC, Teixeira SA, Villela LH, et al. Prevalence of HTLV-1/2 in pregnant women living in the metropolitan area of Rio de Janeiro. PLoS Negl Trop Dis. 2014;8(9). e3146. doi: 10.1371/journal.pntd.0003146. [PubMed: 25188386]. [PubMed Central: PMC4154655].
  • 27. Yamada T, Togashi T, Tsutsumi H, Imamura M, Okubo H, Okabe M, et al. Prevalence of human T‐lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan. Microbiol Immun. 2014;58(8):427-31.
  • 28. Hatami H, Karimi GH, Safabakhsh HR. Seroepidemiologic prevalence of HTLV in voluntary blood donors in Mashhad. Sci J Iran Blood Transfusion Organization. 2012;9(2).
  • 29. Karimi G, Zadsar M, Pourfathollah AA. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virol J. 2017;14(1):14. doi: 10.1186/s12985-017-0693-9. [PubMed: 28137274]. [PubMed Central: PMC5282699].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments